首页> 外文OA文献 >PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODERATE-TO-HIGH RISK OF RECURRENCE IN CHINA

【2h】

PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODERATE-TO-HIGH RISK OF RECURRENCE IN CHINA

机译：PCN195在乳房切除术后，雌激素内分泌治疗的Leuplolide 3个月的成本和Goserelin 1对化合物的成本比较，具有早期前期前期雌激素受体阳性乳腺癌的辅助内分泌治疗，雌激素受体阳性乳腺癌在中国中度至高的高度患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
L. Fan; Z. Wang; Y.C. Yeh; F. Du; G. Liu; C. Zheng; L. Zheng; X. Gao;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers [J] . Khan Sabrina S., Karn Thomas, Symmans W. Fraser, Breast cancer research and treatment. . 2015,第3期

机译：高风险雌激素受体阳性乳腺癌辅助化疗和内分泌治疗后复发残留风险的基因组预测因子
2. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery [J] . Murphy Colin T., Li Tianyu, Wang Lora S., Clinical breast cancer . 2015,第5期

机译：保乳手术治疗早期激素受体阳性乳腺癌老年妇女单独放疗与放疗和内分泌治疗的比较
3. Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer. [J] . Sugimachi K, Maehara Y, Akazawa K, Breast cancer research and treatment. . 1999,第2期

机译：丝裂霉素C，他莫昔芬和UFT的术后化学内分泌治疗对绝经前雌激素受体阳性的II期乳腺癌患者有效。 Nishinihon乳腺癌辅助治疗合作研究组。
4. Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer [O] . Zhen-Yu Wu, Young-jin Lee, Heejeong Kim, 2021

机译：6个月的22.5mg血红蛋白贮库制剂的疗效与他莫昔芬在激素受体阳性乳腺癌中术后前辈雌激素抑制的疗效
5. Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer [O] . Tsui Fen Cheng, Jung Der Wang, Wu Ching Uen 2012

机译：围绝经前乳腺癌患者辅助使用戈舍瑞林（Zoladex）和辅助化疗的成本-效用分析

PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODERATE-TO-HIGH RISK OF RECURRENCE IN CHINA

著录项

相似文献

相关主题

期刊订阅